Junji Yonese

Ariake, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Moderately hypofractionated intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: five-year results from a single-institution study in Japan.

Moderately hypofractionated intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: five-year results from a single-institution study in Japan.

Journal: International journal of clinical oncology

Published: May 15, 2026

Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects.

Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: April 04, 2026

Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: April 03, 2026

External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinations.

External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinations.

Journal: International urology and nephrology

Published: March 15, 2026

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Journal: Japanese journal of clinical oncology

Published: January 22, 2026

Unclassified Renal Cell Carcinoma with Reverse Polarity and Pathogenic von Hippel-Lindau Mutation in a Congenital Renal Malformation.

Unclassified Renal Cell Carcinoma with Reverse Polarity and Pathogenic von Hippel-Lindau Mutation in a Congenital Renal Malformation.

Journal: International journal of surgical pathology

Published: August 18, 2025

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone.

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone.

Journal: Clinical case reports

Published: July 23, 2025

Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review.

Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review.

Journal: Expert review of anticancer therapy

Published: April 10, 2025

Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study.

Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 06, 2025

Genomic features of bladder neuroendocrine carcinoma with composite histology.

Genomic features of bladder neuroendocrine carcinoma with composite histology.

Journal: Histology and histopathology

Published: February 27, 2025

An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch Syndrome.

An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch Syndrome.

Journal: IJU case reports

Published: February 19, 2025

Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma.

Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma.

Journal: BMC cancer

Published: January 31, 2025

Showing 1-12 of 194

Last Updated: 09/26/2026